Shares

59 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$33.68 - $41.95 $18,726 - $23,324
-556 Reduced 7.54%
6,821 $277,000
Q4 2023

Feb 14, 2024

SELL
$33.32 - $42.1 $10,295 - $13,008
-309 Reduced 4.02%
7,377 $272,000
Q3 2023

Nov 14, 2023

BUY
$36.46 - $44.03 $14,037 - $16,951
385 Added 5.27%
7,686 $293,000
Q2 2023

Aug 10, 2023

BUY
$30.28 - $38.74 $3,209 - $4,106
106 Added 1.47%
7,301 $263,000
Q1 2023

May 15, 2023

SELL
$32.86 - $55.7 $33,287 - $56,424
-1,013 Reduced 12.34%
7,195 $274,000
Q4 2022

Jun 14, 2023

BUY
$40.06 - $59.44 $40,580 - $60,212
1,013 Added 14.08%
8,208 $467 Million
Q4 2022

Mar 30, 2023

BUY
$40.06 - $59.44 $1,201 - $1,783
30 Added 0.37%
8,208 $467,000
Q4 2022

Feb 15, 2023

BUY
$40.06 - $59.44 $1,201 - $1,783
30 Added 0.37%
8,208 $467,000
Q3 2022

Jun 14, 2023

BUY
$38.53 - $51.78 $37,874 - $50,899
983 Added 13.66%
8,178 $323 Million
Q2 2022

Jun 20, 2023

BUY
$37.35 - $48.3 $36,715 - $47,478
983 Added 13.66%
8,178 $359,000
Q2 2022

Mar 30, 2023

SELL
$37.35 - $48.3 $19,309 - $24,971
-517 Reduced 5.95%
8,178 $359,000
Q2 2022

Aug 11, 2022

SELL
$37.35 - $48.3 $19,309 - $24,971
-517 Reduced 5.95%
8,178 $360,000
Q1 2022

Jun 20, 2023

BUY
$31.97 - $41.06 $47,955 - $61,590
1,500 Added 20.85%
8,695 $346,000
Q1 2022

Mar 30, 2023

SELL
$31.97 - $41.06 $1.57 Million - $2.01 Million
-49,044 Reduced 84.94%
8,695 $346,000
Q1 2022

May 12, 2022

SELL
$31.97 - $41.06 $1.57 Million - $2.01 Million
-49,044 Reduced 84.94%
8,695 $347,000
Q4 2021

Jun 21, 2023

BUY
$31.82 - $40.75 $1.61 Million - $2.06 Million
50,544 Added 702.49%
57,739 $2.32 Million
Q4 2021

Mar 30, 2023

SELL
$31.82 - $40.75 $85,245 - $109,169
-2,679 Reduced 4.43%
57,739 $2.32 Million
Q4 2021

Feb 15, 2022

SELL
$31.82 - $40.75 $85,245 - $109,169
-2,679 Reduced 4.43%
57,739 $2.32 Million
Q3 2021

Jun 21, 2023

BUY
$38.47 - $46.42 $2.05 Million - $2.47 Million
53,223 Added 739.72%
60,418 $2.46 Million
Q3 2021

Mar 30, 2023

SELL
$38.47 - $46.42 $15,003 - $18,103
-390 Reduced 0.64%
60,418 $2.46 Million
Q3 2021

Nov 15, 2021

SELL
$38.47 - $46.42 $15,003 - $18,103
-390 Reduced 0.64%
60,418 $2.46 Million
Q2 2021

Jun 21, 2023

BUY
$38.84 - $51.31 $2.08 Million - $2.75 Million
53,613 Added 745.14%
60,808 $2.76 Million
Q2 2021

Mar 30, 2023

BUY
$38.84 - $51.31 $169,614 - $224,070
4,367 Added 7.74%
60,808 $2.76 Million
Q2 2021

Aug 16, 2021

BUY
$38.84 - $51.31 $2.36 Million - $3.12 Million
60,752 Added 108485.71%
60,808 $2.76 Million
Q1 2021

Jun 26, 2023

BUY
$39.51 - $51.45 $1.95 Million - $2.53 Million
49,246 Added 684.45%
56,441 $2.35 Billion
Q1 2021

Mar 30, 2023

SELL
$39.51 - $51.45 $71,434 - $93,021
-1,808 Reduced 3.1%
56,441 $2.35 Million
Q1 2021

May 14, 2021

SELL
$39.51 - $51.45 $2.3 Million - $2.99 Million
-58,193 Reduced 99.9%
56 $2.35 Million
Q4 2020

Jun 22, 2023

BUY
$25.81 - $43.62 $1.32 Million - $2.23 Million
51,054 Added 709.58%
58,249 $2.49 Million
Q4 2020

Mar 30, 2023

BUY
$25.81 - $43.62 $472,271 - $798,158
18,298 Added 45.8%
58,249 $2.49 Million
Q4 2020

Feb 16, 2021

BUY
$25.81 - $43.62 $472,271 - $798,158
18,298 Added 45.8%
58,249 $2.49 Million
Q3 2020

Jun 26, 2023

BUY
$25.74 - $29.63 $843,139 - $970,560
32,756 Added 455.26%
39,951 $1.05 Million
Q3 2020

Mar 30, 2023

SELL
$25.74 - $29.63 $60,308 - $69,423
-2,343 Reduced 5.54%
39,951 $1.05 Million
Q3 2020

Nov 13, 2020

SELL
$25.74 - $29.63 $60,308 - $69,423
-2,343 Reduced 5.54%
39,951 $1.05 Million
Q2 2020

Jun 26, 2023

BUY
$16.25 - $26.81 $570,358 - $941,004
35,099 Added 487.82%
42,294 $1.13 Million
Q2 2020

Mar 30, 2023

BUY
$16.25 - $26.81 $28,908 - $47,694
1,779 Added 4.39%
42,294 $1.13 Million
Q2 2020

Aug 14, 2020

BUY
$16.25 - $26.81 $28,908 - $47,694
1,779 Added 4.39%
42,294 $1.13 Million
Q1 2020

Jul 12, 2023

BUY
$13.9 - $21.83 $463,148 - $727,375
33,320 Added 463.1%
40,515 $728,000
Q1 2020

Mar 30, 2023

SELL
$13.9 - $21.83 $69,791 - $109,608
-5,021 Reduced 11.03%
40,515 $728,000
Q1 2020

May 15, 2020

SELL
$13.9 - $21.83 $69,791 - $109,608
-5,021 Reduced 11.03%
40,515 $729,000
Q4 2019

Jul 12, 2023

BUY
$14.93 - $19.53 $572,431 - $748,799
38,341 Added 532.88%
45,536 $807,000
Q4 2019

Mar 30, 2023

SELL
$14.93 - $19.53 $16,870 - $22,068
-1,130 Reduced 2.42%
45,536 $807,000
Q4 2019

Feb 14, 2020

SELL
$14.93 - $19.53 $16,870 - $22,068
-1,130 Reduced 2.42%
45,536 $807,000
Q3 2019

Jul 12, 2023

BUY
$15.2 - $17.69 $599,959 - $698,241
39,471 Added 548.59%
46,666 $723,000
Q3 2019

Mar 30, 2023

BUY
$15.2 - $17.69 $91,716 - $106,741
6,034 Added 14.85%
46,666 $723,000
Q3 2019

Nov 14, 2019

BUY
$15.2 - $17.69 $91,716 - $106,741
6,034 Added 14.85%
46,666 $724,000
Q2 2019

Jul 12, 2023

BUY
$14.75 - $17.26 $512,061 - $599,198
34,716 Added 482.5%
41,911 $720,000
Q1 2019

Jul 13, 2023

BUY
$13.94 - $17.58 $466,111 - $587,822
33,437 Added 464.73%
40,632 $654,000
Q1 2019

Mar 30, 2023

BUY
$13.94 - $17.58 $451,990 - $570,013
32,424 Added 395.03%
40,632 $654,000
Q1 2019

May 16, 2019

SELL
$13.94 - $17.58 $273,739 - $345,218
-19,637 Reduced 32.58%
40,632 $654,000
Q1 2019

May 15, 2019

BUY
$13.94 - $17.58 $273,739 - $345,218
19,637 Added 48.33%
60,269 $853,000
Q4 2018

Jul 13, 2023

BUY
$13.33 - $18.66 $445,715 - $623,934
33,437 Added 464.73%
40,632 $594,000
Q4 2018

Feb 14, 2019

BUY
$13.33 - $18.66 $423,014 - $592,156
31,734 Added 356.64%
40,632 $594,000
Q3 2018

Jul 13, 2023

BUY
$16.68 - $18.41 $557,729 - $615,575
33,437 Added 464.73%
40,632 $738 Million
Q3 2018

Nov 14, 2018

SELL
$16.68 - $18.41 $529,323 - $584,222
-31,734 Reduced 78.1%
8,898 $162,000
Q2 2018

Aug 15, 2018

BUY
$16.87 - $20.3 $38,598 - $46,446
2,288 Added 5.97%
40,632 $0
Q1 2018

May 15, 2018

BUY
$17.06 - $21.2 $12,760 - $15,857
748 Added 1.99%
38,344 $0
Q4 2017

Feb 15, 2018

SELL
$16.75 - $20.8 $703,634 - $873,766
-42,008 Reduced 52.77%
37,596 $762,000
Q3 2017

Nov 14, 2017

BUY
$11.76 - $17.4 $60,293 - $89,209
5,127 Added 6.88%
79,604 $1.38 Million
Q2 2017

Aug 14, 2017

BUY
N/A
74,477
74,477 $955,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.